Atea Pharmaceuticals Inc
NASDAQ:AVIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
Barry Callebaut AG
SIX:BARN
|
CH |
|
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
US |
|
R
|
RPC Inc
NYSE:RES
|
US |
|
A
|
Audax Renovables SA
SWB:54F
|
ES |
|
S
|
Sanlam Ltd
JSE:SLM
|
ZA |
|
OUTFRONT Media Inc
NYSE:OUT
|
US |
Intrinsic Value
The intrinsic value for
Atea Pharmaceuticals Inc (AVIR) under the Base Case is hidden
USD.
Compared with the current market price of 4.21 USD, the stock appears hidden
.
AVIR looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether AVIR usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Atea Pharmaceuticals Inc.
The intrinsic value for
Atea Pharmaceuticals Inc (AVIR) under the Base Case is hidden USD.
Compared with the current market price of 4.21 USD, the stock appears hidden.